NCT03956680 2025-02-19An Investigational Immunotherapy Study of BMS-986301 Alone or in Combination With Nivolumab, and Ipilimumab in Participants With Advanced Solid CancersBristol-Myers SquibbPhase 1 Completed54 enrolled